Domperidone API Manufacturer & Bulk Supplier in India | Swapnroop Drugs & Pharmaceuticals
Domperidone API Manufacturer & Bulk Supplier in India | Swapnroop Drugs & Pharmaceuticals
1. Introduction
Domperidone is a synthetic pharmaceutical compound belonging to the dopamine D2-receptor antagonist class. It is primarily used in selected medicines for the management of nausea and vomiting. It also has prokinetic properties, which means it can influence the movement of food through the upper gastrointestinal tract.
Domperidone acts mainly on peripheral dopamine receptors, including receptors involved in gastrointestinal movement and the regulation of nausea and vomiting. By blocking dopamine D2 receptors, it can improve gastric motility and produce an antiemetic effect.
In pharmaceutical manufacturing, domperidone maleate is an important salt form used in oral tablet preparations. The free-base form is also relevant to pharmaceutical development and certain formulations. These forms have different molecular weights, CAS numbers, and specifications.
For pharmaceutical manufacturers, selecting the correct chemical form and verifying assay, related substances, residual solvents, and applicable pharmacopoeial requirements are essential quality considerations.
Swapnroop Drugs & Pharmaceuticals welcomes pharmaceutical-sector product enquiries and sourcing discussions. Product grade, availability, specifications, and supporting documentation should be confirmed for each specific requirement.
2. What Is Domperidone API?
Domperidone is a synthetic dopamine antagonist with antiemetic and gastroprokinetic properties. It belongs to the benzimidazolone and heteroarylpiperidine chemical groups.
Its principal pharmacological activity involves blocking dopamine D2 receptors. This action can influence gastrointestinal movement and reduce nausea and vomiting.
Domperidone is used in selected pharmaceutical formulations for:
Symptomatic relief of nausea and vomiting
Selected gastrointestinal motility-related conditions, where authorised
Oral antiemetic preparations
Pharmaceutical combination and formulation research
The most commonly referenced salt form in tablet products is domperidone maleate, also known as domperidone monomaleate.
Key characteristics
Product name: Domperidone
Common pharmaceutical salt: Domperidone maleate
CAS number of free base: 57808-66-9
CAS number of maleate: 83898-65-1
Pharmacological class: Dopamine D2-receptor antagonist
Therapeutic category: Antiemetic
Chemical class: Benzimidazolone derivative
Main pharmacological action: Antiemetic and gastroprokinetic
Common dosage form: Oral tablets
3. Domperidone API – Chemical Information
Domperidone and domperidone maleate are related but chemically distinct forms. The maleate salt contains one molecule of maleic acid for each molecule of domperidone.
| Parameter | Domperidone Free Base | Domperidone Maleate |
|---|---|---|
| Product Name | Domperidone | Domperidone Maleate |
| CAS Number | 57808-66-9 | 83898-65-1 |
| Molecular Formula | C₂₂H₂₄ClN₅O₂ | C₂₂H₂₄ClN₅O₂·C₄H₄O₄ |
| Combined Formula | C₂₂H₂₄ClN₅O₂ | C₂₆H₂₈ClN₅O₆ |
| Molecular Weight | 425.91 g/mol | 541.98 g/mol |
| Chemical Category | Dopamine antagonist | Maleate salt of domperidone |
| Pharmacological Class | Antiemetic | Antiemetic |
| Therapeutic Application | Nausea and vomiting management | Nausea and vomiting management |
Important: The article primarily focuses on domperidone maleate. Its molecular weight of approximately 541.98 g/mol must not be confused with the free-base molecular weight of approximately 425.91 g/mol. Assay calculations and product specifications should identify the exact form and basis of calculation.
4. Chemical Structure and Properties of Domperidone
Domperidone has a complex organic molecular structure containing two benzimidazolone-related ring systems connected through a propyl chain and a piperidine ring.
Its structure includes:
A chlorine-substituted aromatic ring
Benzimidazolone ring systems
A piperidine ring
A propyl linker
Nitrogen-containing heterocyclic groups
Carbonyl functional groups
These structural features contribute to the compound's interaction with dopamine receptors.
Important chemical characteristics
1. Benzimidazolone structure
Domperidone contains benzimidazolone-related structural units that contribute to its molecular identity and physicochemical properties.
2. Piperidine ring
The piperidine component is connected to the molecular framework through a propyl linker and contributes to the compound's chemical structure.
3. Chlorine substitution
A chlorine atom is present on one of the aromatic ring systems.
4. Maleate salt formation
Domperidone maleate is formed through association of domperidone with maleic acid. The salt has a different molecular weight and chemical composition from the free base.
5. Solubility characteristics
The free base and maleate salt have different physicochemical characteristics. Solubility should be assessed using the actual chemical form and the test conditions specified in the applicable product specification.
5. Mechanism of Action of Domperidone
Domperidone acts primarily by blocking dopamine D2 receptors.
Dopamine is a neurotransmitter involved in several physiological processes, including gastrointestinal regulation and the control of nausea and vomiting.
By blocking selected dopamine receptors, domperidone produces antiemetic and gastroprokinetic effects.
5.1 Peripheral Dopamine D2-Receptor Antagonism
Domperidone blocks dopamine D2 receptors, particularly those involved in gastrointestinal regulation.
This action reduces dopamine-mediated inhibition of gastrointestinal movement and contributes to its prokinetic properties.
5.2 Gastroprokinetic Activity
Domperidone can improve gastric motility and promote gastric emptying.
Its effects are associated with:
Increased gastric peristalsis
Improved gastric emptying
Changes in upper gastrointestinal motility
Modulation of gastrointestinal coordination
5.3 Antiemetic Activity
Domperidone also acts on dopamine receptors associated with the chemoreceptor trigger zone, an area involved in the regulation of nausea and vomiting.
By blocking dopamine-mediated signalling in this pathway, domperidone can help reduce nausea and vomiting.
5.4 Prolactin Release
Dopamine normally inhibits prolactin secretion from the pituitary gland. Domperidone's dopamine-receptor blocking activity can therefore increase prolactin levels.
This effect is also associated with certain endocrine-related adverse effects.
6. Pharmaceutical Applications of Domperidone API
Domperidone is used in selected pharmaceutical preparations for gastrointestinal and antiemetic applications.
6.1 Nausea and Vomiting
Domperidone is used in certain markets for the short-term symptomatic relief of nausea and vomiting.
Its antiemetic activity is associated with dopamine D2-receptor antagonism.
The approved indications depend on the country, product label, and applicable regulatory restrictions.
6.2 Gastrointestinal Motility
Domperidone has gastroprokinetic properties and may be used in selected settings involving delayed gastric emptying or upper gastrointestinal motility symptoms, where permitted by local product authorisation.
However, regulatory authorities have restricted some previously promoted indications because the available benefit-risk evidence does not support unrestricted use.
6.3 Oral Antiemetic Formulations
Domperidone maleate is used in oral pharmaceutical formulations, particularly tablet preparations.
These products are designed to provide a controlled quantity of the active pharmaceutical ingredient in accordance with the approved product specification.
6.4 Pharmaceutical Research
Domperidone may be relevant to research involving:
Dopamine receptor antagonism
Gastrointestinal pharmacology
Antiemetic formulation development
Drug-excipient compatibility
Analytical method development
Stability evaluation
7. Pharmaceutical Dosage Forms Containing Domperidone
Domperidone has been incorporated into different pharmaceutical dosage forms depending on the market and product authorisation.
| Dosage Form | General Application |
|---|---|
| Tablets | Oral antiemetic preparations |
| Oral Suspensions | Selected liquid formulations |
| Oral Solutions | Selected formulations where authorised |
| Combination Products | Selected products containing additional active ingredients |
The free base and maleate salt may be used differently depending on formulation requirements.
Manufacturers must confirm the intended active form, equivalent active-moiety quantity, and applicable finished-product specification.
8. Manufacturing and Processing Considerations
Domperidone maleate is a synthetic pharmaceutical compound. Its manufacturing involves controlled chemical synthesis, purification, salt formation, isolation, and quality evaluation.
The actual manufacturing route depends on the validated process and approved manufacturing controls.
8.1 Starting Material Qualification
Starting materials should be assessed before use.
Important considerations include:
Chemical identity
Purity
Impurity profile
Supplier qualification
Batch traceability
Compliance with the applicable specification
8.2 Chemical Synthesis
The manufacturing process involves controlled chemical transformations to produce the domperidone molecular structure.
Process controls are important for maintaining the intended molecular identity and limiting unwanted impurities.
8.3 Purification
Purification operations help remove unreacted starting materials, intermediates, and process-related impurities.
Appropriate purification controls are necessary to achieve the required material quality.
8.4 Maleate Salt Formation
The domperidone free-base compound is converted into its maleate salt using maleic acid under controlled processing conditions.
Salt formation must be controlled to ensure the correct stoichiometric form and product quality.
8.5 Crystallisation and Isolation
Crystallisation and isolation operations are used to obtain the final solid material.
The process should be controlled to maintain appropriate physical characteristics and batch consistency.
8.6 Drying and Packaging
The material is dried and packaged according to the approved manufacturing process.
Packaging should protect the API from contamination and unsuitable environmental exposure.
Note: This is a general pharmaceutical manufacturing overview, not a validated manufacturing procedure or a claim regarding SDP's manufacturing capabilities.
9. Quality Control and Testing of Domperidone Maleate
Quality control is essential for ensuring that domperidone maleate meets the applicable pharmaceutical specification.
A suitable testing programme should evaluate chemical identity, assay, impurities, water-related parameters, and other relevant quality attributes.
9.1 Identification Testing
Identification tests confirm that the material corresponds to domperidone maleate.
Possible approaches include:
Infrared spectroscopy
Chromatographic identification
Other applicable pharmacopoeial identification tests
9.2 Assay Testing
Assay testing determines the quantity of domperidone maleate present in the material.
The British Pharmacopoeia and European Pharmacopoeia provide reference standards for domperidone maleate.
The assay method and acceptance criteria should follow the applicable current monograph and approved product specification.
9.3 Related Substances
Related-substance testing evaluates impurities associated with synthesis, processing, or degradation.
Chromatographic methods may be used to separate and evaluate specified and unspecified impurities.
9.4 Loss on Drying
Loss on drying may be used to assess moisture and other volatile components, depending on the applicable specification.
9.5 Sulphated Ash
Sulphated ash testing may be used to evaluate inorganic residue, where required by the applicable monograph.
9.6 Residual Solvents
Residual solvent testing may be required depending on the manufacturing process and relevant regulatory requirements.
9.7 Appearance
Visual inspection helps identify unexpected changes in colour, physical condition, or visible contamination.
9.8 Packaging Integrity
Packaging should be inspected to confirm:
Container integrity
Correct closure
Appropriate labelling
Batch identification
Protection against contamination
10. Analytical Methods Used for Domperidone API
Several analytical techniques may be used to evaluate domperidone maleate.
| Analytical Method | Purpose |
|---|---|
| HPLC | Assay and related-substances analysis |
| FTIR Spectroscopy | Chemical identification |
| UV-Visible Spectroscopy | Selected quantitative analytical applications |
| Gas Chromatography | Residual solvent analysis, where applicable |
| Karl Fischer Titration | Water-content determination, where specified |
| Loss on Drying | Evaluation of moisture and volatile matter |
| Sulphated Ash | Evaluation of inorganic residue |
| Visual Examination | Appearance and physical quality assessment |
The actual testing programme should be based on the applicable pharmacopoeial monograph, validated methods, and approved product specification.
11. Storage and Handling of Domperidone Maleate
Proper storage and handling help maintain the quality and integrity of domperidone maleate.
The storage conditions should follow the applicable product specification and supporting stability data.
Storage considerations
Use suitable, well-closed containers.
Protect the material from light where required by the applicable specification.
Prevent contamination during storage and sampling.
Maintain appropriate warehouse conditions.
Follow the manufacturer's storage recommendations.
Maintain batch identification and traceability.
Use suitable packaging materials.
Handling precautions
Personnel handling domperidone maleate should:
Consult the current Safety Data Sheet.
Use suitable protective gloves.
Wear appropriate eye protection.
Avoid unnecessary dust generation.
Prevent accidental ingestion and direct exposure.
Follow workplace hygiene procedures.
Use approved sampling and dispensing controls.
12. Safety and Regulatory Considerations
Domperidone has important cardiac safety considerations that must be addressed during pharmaceutical development, product labelling, and clinical use.
12.1 QT Interval Prolongation
Domperidone has been associated with QT interval prolongation, a change in the heart's electrical activity that can increase the risk of serious cardiac arrhythmias.
12.2 Ventricular Arrhythmias
Serious cardiac events, including ventricular arrhythmias and sudden cardiac death, have been reported in association with domperidone use.
Risk may be higher in certain patient groups and when domperidone is used with medicines that increase cardiac risk.
12.3 Risk Factors
Regulatory reviews have identified particular concerns involving:
Older patients, especially those over 60 years
Higher daily doses
Existing cardiac conditions
Concomitant use of QT-prolonging medicines
Use with strong CYP3A4 inhibitors
12.4 Regulatory Restrictions
The European Medicines Agency reviewed domperidone-containing medicines and recommended restrictions to reduce cardiac risk.
The EU review restricted authorised use primarily to relief of nausea and vomiting, with dose and duration limitations. The maximum treatment duration is generally recommended not to exceed one week under the reviewed guidance.
The exact restrictions differ between countries and must be checked against the current local product authorisation.
12.5 US Regulatory Status
The US FDA states that domperidone is not approved for human use in the United States. The agency has also warned about serious cardiac adverse events associated with its use, including QT prolongation, cardiac arrest, and sudden death.
12.6 Regulatory Considerations for Manufacturers
Pharmaceutical manufacturers should evaluate:
Applicable national marketing authorisation
GMP requirements
API identity and impurity controls
Validated analytical methods
Stability data
Finished-product safety information
Packaging and labelling requirements
Regulatory pharmacovigilance obligations
Product registration and commercial use must follow the requirements of the intended market.
13. Difference Between Domperidone and Domperidone Maleate
Domperidone and domperidone maleate are related chemical forms, but they have different molecular compositions and molecular weights.
| Parameter | Domperidone | Domperidone Maleate |
|---|---|---|
| Chemical Form | Free base | Maleate salt |
| CAS Number | 57808-66-9 | 83898-65-1 |
| Molecular Formula | C₂₂H₂₄ClN₅O₂ | C₂₂H₂₄ClN₅O₂·C₄H₄O₄ |
| Molecular Weight | 425.91 g/mol | 541.98 g/mol |
| Common Pharmaceutical Context | Free-base formulations and development | Common oral tablet salt form |
| Active Moiety | Domperidone | Domperidone |
The active moiety is domperidone in both forms. However, the quantity of maleate salt required to provide a specified amount of domperidone differs from the free-base quantity.
Manufacturers must use the correct salt-to-active-moiety conversion when calculating formulation quantities and labelling strengths.
14. Pharmaceutical Procurement Considerations
Pharmaceutical manufacturers and procurement teams should evaluate several factors before sourcing domperidone maleate.
14.1 Confirm the Chemical Form
Specify whether the requirement is for domperidone free base or domperidone maleate.
14.2 Confirm the Applicable Grade
Identify the required pharmaceutical grade and applicable pharmacopoeial standard, such as BP or Ph. Eur., where relevant.
14.3 Review the Certificate of Analysis
A batch-specific CoA should include actual test results, analytical methods, and acceptance criteria.
14.4 Evaluate Impurity Controls
Review related substances, residual solvents, and other relevant process-related impurities.
14.5 Confirm Assay Basis
Verify whether the assay is expressed as domperidone maleate or calculated as domperidone active moiety.
14.6 Review Supplier Documentation
Depending on the intended application, buyers may request:
Batch-specific Certificate of Analysis
Product specification
Safety Data Sheet
Manufacturing and testing information
Stability data
Relevant compliance declarations
Packaging information
14.7 Confirm Regulatory Suitability
Verify that the intended product and use comply with the regulatory requirements of the destination market.
15. Domperidone API Market and Pharmaceutical Industry Relevance
Domperidone has an established role in selected antiemetic and gastrointestinal pharmaceutical products.
Its dopamine-receptor antagonist activity makes it relevant to pharmaceutical formulations intended for nausea and vomiting management.
Important industry considerations include:
Consistent chemical quality
Correct maleate salt identification
Accurate assay calculations
Related-substance control
Reliable analytical testing
Formulation compatibility
Stability assessment
Regulatory compliance
Complete batch documentation
Because of cardiac safety concerns and country-specific restrictions, pharmaceutical manufacturers must evaluate the regulatory status and approved indications of domperidone-containing products in each target market.
16. Domperidone API Enquiries – Swapnroop Drugs & Pharmaceuticals
Swapnroop Drugs & Pharmaceuticals welcomes product-related business enquiries from pharmaceutical manufacturers, formulation developers, distributors, and procurement professionals.
For a Domperidone API enquiry, buyers should specify:
Product name: Domperidone Maleate
CAS number: 83898-65-1
Molecular formula: C₂₆H₂₈ClN₅O₆
Molecular weight: 541.98 g/mol
Required pharmaceutical grade
Applicable pharmacopoeial specification
Required quantity
Intended dosage form
Documentation requirements
Destination market
Product identity, availability, grade, documentation, and regulatory suitability should be confirmed directly before any purchase commitment.
Contact Swapnroop Drugs & Pharmaceuticals for product-related business enquiries and sourcing discussions.
17. Frequently Asked Questions (FAQs)
Q1. What is Domperidone API?
Domperidone is a synthetic dopamine D2-receptor antagonist used in selected pharmaceutical products for nausea and vomiting management. It also has gastroprokinetic properties.
Q2. What is the CAS number of Domperidone?
The CAS number of domperidone free base is 57808-66-9.
Q3. What is the CAS number of Domperidone Maleate?
The CAS number of domperidone maleate is 83898-65-1.
Q4. What is the molecular formula of Domperidone Maleate?
The molecular formula is C₂₂H₂₄ClN₅O₂·C₄H₄O₄, also represented as C₂₆H₂₈ClN₅O₆.
Q5. What is the molecular weight of Domperidone Maleate?
Its molecular weight is approximately 541.98 g/mol.
Q6. What is the difference between Domperidone and Domperidone Maleate?
Domperidone is the free-base compound, whereas domperidone maleate is its salt formed with maleic acid. They have different CAS numbers, molecular formulas, and molecular weights.
Q7. How does Domperidone work?
Domperidone blocks dopamine D2 receptors, helping reduce nausea and vomiting and influencing upper gastrointestinal motility.
Q8. What are the pharmaceutical applications of Domperidone?
It is used in selected oral pharmaceutical formulations for symptomatic relief of nausea and vomiting, subject to local regulatory approval.
Q9. What quality tests are important for Domperidone Maleate?
Important tests include identification, assay, related substances, loss on drying, residual solvents where applicable, and other tests required by the applicable specification.
Q10. Why is cardiac safety important for Domperidone?
Domperidone has been associated with QT prolongation, ventricular arrhythmias, and sudden cardiac death. Regulatory authorities have therefore restricted its use in certain markets and patient groups.
Q11. Is Domperidone approved in the United States?
The US FDA states that domperidone is not approved for human use in the United States.
Q12. What documents should be reviewed when sourcing Domperidone API?
Buyers should review a batch-specific Certificate of Analysis, product specification, Safety Data Sheet, manufacturing and testing information, stability data, and relevant regulatory documentation.
Conclusion
Domperidone is a synthetic dopamine D2-receptor antagonist with antiemetic and gastroprokinetic properties. It is used in selected pharmaceutical preparations for the symptomatic management of nausea and vomiting.
Domperidone maleate is an important pharmaceutical salt form used in oral formulations. Correct identification of the free base and maleate salt is essential for product specifications, assay calculations, formulation development, and procurement.
Quality evaluation should address identity, assay, related substances, moisture-related parameters, packaging, and batch documentation. In addition, cardiac safety and market-specific regulatory restrictions must be considered when developing or supplying domperidone-containing products.
Swapnroop Drugs & Pharmaceuticals welcomes product-related business enquiries from pharmaceutical manufacturers, distributors, and procurement professionals. Product grade, availability, documentation, and regulatory suitability should be verified before procurement.

Comments
Post a Comment